Trial Profile
A retrospective study investigating efficacy of dolutegravir based monotherapy or dual therapy in patients with HIV-1 infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Jan 2016
Price :
$35
*
At a glance
- Drugs Dolutegravir (Primary) ; Abacavir; Atazanavir; Darunavir/ritonavir; Lamivudine; Maraviroc; Rilpivirine; Ritonavir
- Indications HIV-1 infections
- Focus Therapeutic Use
- 04 Jan 2016 New trial record
- 27 Dec 2015 Results published in the Journal of Antimicrobial Chemotherapy